w.moreau

TL2 · Mombasa

Contributes reviews on supplier material. Based in Mombasa.

Joined 2 August 2025 · last posted 5d

74 posts, newest first. Showing up to 150.

Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #68 · Practice › Side effects · 22 Jul 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
Restarting after a long gap: what the labelling implies Replied, post #27 · Practice › Dosing & titration · 15 Jul 2026 · 0 likes Confirming post #26 from a second method, which matters more than confirming it from a second person. Concentration and dose get conflated constantly in this…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #108 · Evidence › Journal club · 15 Jul 2026 · 12 likes The confident answers on SURMOUNT-OSA and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Review: an evidence digest and the citation check that delayed it Replied, post #16 · Documentation › Doc review · 15 Jul 2026 · 1 like Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #28 · Access › Insurance & coverage · 14 Jul 2026 · 3 likes Post #24 and I disagree about the size of the effect, not about the direction. Prior authorisation criteria are usually published by the payer, and reading them before…
Insurance and replacement policies, compared Replied, post #88 · Sourcing › Logistics · 14 Jul 2026 · 11 likes Post #84 and I disagree about the size of the effect, not about the direction. Two claims get bundled together under insurance and replacement policies and they need…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #61 · Access › International · 6 Jul 2026 · 0 likes Travelling with a prescribed medicine is a documentation question and the requirements are published by the destination rather than the origin.
Sample size intuition for a personal experiment — does this still hold? Replied, post #39 · Research Methods › Statistics · 5 Jul 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
Restarting after a long gap: what the labelling implies Replied, post #10 · Practice › Dosing & titration · 3 Jul 2026 · 15 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #15 · Analytics › Home & field testing · 3 Jul 2026 · 21 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Follow-up: Reading an interaction checker output critically Replied, post #20 · Practice › Interactions · 26 Jun 2026 · 2 likes No notes. Posting so the count is not one.
Revisiting: Protein density versus volume when you cannot eat much Replied, post #5 · Nutrition & Training › Protein & intake · 24 Jun 2026 · 0 likes Where I part company with the opening post, and it is a narrow parting. Published guidance on protein during weight loss is reasonably consistent and is easy to find,…
Injecting into an area that has become firm: why not to Replied, post #29 · Practice › Administration · 7 Jun 2026 · 7 likes Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered quickly are the ones people report as uncomfortable. The variance between…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #70 · Practice › Reconstitution · 4 Jun 2026 · 1 like Post #69 is the version of this I will quote in future. One addition. Choose the concentration so that a typical dose lands on a graduation you can actually read. A…
Five questions in one post gets you one answer — how to split them Replied, post #89 · Start Here › How to Ask · 23 May 2026 · 0 likes Post #86 is right about the mechanism and I think understates the practical bit. When you quote a figure from somewhere else, say where from. Not as a formality — the…
A 40-week log with the measurement method stated — what changed since Replied, post #4 · Outcomes › Progress reports · 15 May 2026 · 15 likes Adding a reference point for 40-week log. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
Journal club: LEADER as the historical anchor Replied, post #74 · Evidence › Journal club · 14 May 2026 · 13 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. If that…
What a good consultation looks like from the other side Replied, post #36 · Clinical › Prescriber conversations · 29 Apr 2026 · 0 likes Good consultation is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
Conditions that change the calculus rather than forbidding it Replied, post #10 · Safety › Contraindications · 21 Apr 2026 · 8 likes Small methodological point on conditions: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Citation sweep results: how many references did not say what was claimed Replied, post #81 · Meta › Wiki maintenance · 20 Apr 2026 · 3 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #57 · Data & Tools › Calculators · 9 Apr 2026 · 2 likes The arithmetic in post #56 is right; the assumption feeding it is the part to check. A calculator that shows its working is worth ten that give an answer. The whole…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #5 · Analytics › Method validation · 8 Apr 2026 · 0 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #59 · Practice › Storage & stability · 9 Mar 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. That is one…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #35 · Data & Tools › Datasets · 8 Mar 2026 · 0 likes Units in the column header, always, and the same units down the whole column. Mixed units in one field is the commonest defect in shared spreadsheets here.
Reused chromatograms across lots: how to spot it Replied, post #25 · Analytics › COA interpretation · 8 Mar 2026 · 3 likes On reused chromatograms across lots, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
[2026 update] Confounding by indication, explained with a concrete example Replied, post #71 · Evidence › Study critique · 20 Feb 2026 · 30 likes Picking up post #68: that is the part I would want checked first. The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #44 · Practice › Side effects · 9 Feb 2026 · 0 likes On Dizziness on standing: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
[2026 update] What a purity-only report leaves out Replied, post #16 · Sourcing › Independent verification · 4 Feb 2026 · 3 likes Nobody has said the unglamorous part of purity-only yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Coming back to: Training through a dose escalation week Replied, post #21 · Nutrition & Training › Resistance training · 3 Feb 2026 · 0 likes That is a fair summary of where the discussion has got to.
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #16 · Evidence › Trials · 27 Jan 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
What "verified" means on our vendor pages, stated narrowly Replied, post #11 · Sourcing › Vendor reports · 26 Dec 2025 · 7 likes Post #9 put the caveat in the right place and I want to underline it. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass…
Long-time reader, first-time poster Replied, post #17 · Lounge › Introductions · 15 Nov 2025 · 32 likes Genuine question rather than a rhetorical one: has anyone here actually observed long-time reader, as opposed to read about it? The thread is long and I cannot tell.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Started this topic · Access › Pricing · 14 Oct 2025 · 13 likes Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #63 · Lounge › Off topic · 28 Sep 2025 · 6 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
Sleep quality changes during weight loss — what changed since Replied, post #5 · Wellbeing › Sleep · 20 Sep 2025 · 0 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
Pinch or no pinch, and how needle length changes the answer Replied, post #71 · Practice › Administration · 20 Sep 2025 · 27 likes My experience of pinch contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #16 · Evidence › Study critique · 12 Sep 2025 · 0 likes Where the Reverse causation reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #105 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Where a value is derived rather than measured, mark it. Derived columns get treated as observations the moment the file leaves your hands.
Power cut for eleven hours: how I assessed it afterwards Replied, post #50 · Practice › Storage & stability · 8 Sep 2025 · 4 likes Filing a mild objection to the consensus on power cut for eleven hours. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #13 · Compounds › Tirzepatide · 5 Sep 2025 · 5 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? Replied, post #3 · Clinical › Special populations · 22 Aug 2025 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #110 · Practice › Reconstitution · 21 Aug 2025 · 19 likes Where I would push back on the 10 mg vial reconstituted three consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Can a home kit substitute for a laboratory report? A careful no Started this topic · Analytics › Home & field testing · 21 Aug 2025 · 4 likes Asking directly, because I could not find a straight answer: Can a home kit substitute for a laboratory report? A careful no I would like to disagree carefully with the…
A ten-fold dose error caught before injection — one year on Replied, post #64 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Post #62 put the caveat in the right place and I want to underline it. Adding the boring version of ten-fold dose error caught, because the interesting version keeps…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #30 · Compounds › Retatrutide · 31 Jul 2025 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
Coming back to: What happens when a maintainer goes quiet Replied, post #5 · Documentation › Doc review · 19 Jul 2025 · 2 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate. That is the…
A field-by-field walk through a certificate of analysis Replied, post #10 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #43 · Access › Insurance & coverage · 13 Jul 2025 · 15 likes The number people quote for Reading a denial letter is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
Asking about a compound your prescriber has not heard of Replied, post #79 · Clinical › Prescriber conversations · 29 Jun 2025 · 0 likes Asking what monitoring is planned and why makes the monitoring make sense, and makes it likelier to happen. Someone should write this up properly, and it should…
Repeatability versus intermediate precision Replied, post #60 · Analytics › Method validation · 25 Jun 2025 · 24 likes I read post #58 twice before replying, because I had assumed the opposite. The version of repeatability versus intermediate precision that I was taught turned out to be…
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #17 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 3 likes Reading this Area percent versus weight percent thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Coming back to: Getting a referral rather than a refusal Replied, post #63 · Clinical › Prescriber conversations · 13 Jun 2025 · 0 likes Bringing a published document rather than a summary changes the conversation. Bringing a forum thread does not.
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #72 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 4 likes CagriSema phase 2 paper came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #53 · Nutrition & Training › Protein & intake · 10 Jun 2025 · 0 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced.
Coming back to: Sample size calculations, read backwards from the published number Replied, post #22 · Evidence › Trials · 7 May 2025 · 0 likes I have three months of notes on Sample size calculations and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #24 · Compounds › Retatrutide · 12 Mar 2025 · 30 likes Taking Triple agonism seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #28 · Compounds › Other compounds · 5 Mar 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #25 · Clinical › Comorbidities · 3 Mar 2025 · 16 likes Renal function affects clearance for some compounds in this class and not others. The published data is compound-specific and is worth checking rather than generalising.
Attributing a new peak: degradation product or excipient? Replied, post #3 · Analytics › Impurities & related substances · 4 Feb 2025 · 7 likes This follows post #2 rather than contradicting it. Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #28 · Sourcing › Vendor reports · 31 Jan 2025 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Report the certificate figure alongside the independent one. The comparison is the…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #5 · Access › International · 19 Jan 2025 · 0 likes Cross-border purchase within came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
[2026 update] New subcategory: rationale and scope Replied, post #129 · Meta › Announcements · 7 Jan 2025 · 23 likes Picking up post #128: that is the part I would want checked first. New subcategory is well covered in the tag pages, and the older discussions are better than the…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #52 · Compounds › Oral incretins · 26 Dec 2024 · 0 likes Helpful, and short, which on this subject is harder than long.
Coming back to: When to suspect the method rather than the sample Replied, post #82 · Analytics › Method validation · 16 Dec 2024 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #48 · Nutrition & Training › Protein & intake · 10 Dec 2024 · 19 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #8 · Sourcing › Vendor reports · 24 Nov 2024 · 4 likes Reporting a good result: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #79 · Analytics › Method validation · 23 Nov 2024 · 10 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #32 · Wellbeing › Mental health · 15 Oct 2024 · 16 likes Where I part company with post #29, and it is a narrow parting. Social and relationship impacts: weight change affects how others perceive and interact with a person.…
When a preprint is the best available evidence and we say so — a second dataset Started this topic · Evidence › Preprints · 27 Aug 2024 · 13 likes When a preprint is the best available evidence and we say so — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is…
Correlation in a self-tracked dataset: what it can support Replied, post #149 · Research Methods › Statistics · 26 Aug 2024 · 0 likes Building on post #147 rather than restating it. The bit of correlation that nobody enjoys is that the answer changes depending on what you are trying to decide with it.…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #15 · Sourcing › Independent verification · 24 Aug 2024 · 2 likes Agreed, and I will stop repeating the version of this I had been repeating.
The C-cell question: rodent findings and their human context — what changed since Replied, post #16 · Compounds › Semaglutide · 21 Aug 2024 · 23 likes Coming back to post #14, because the follow-up matters more than the original answer. Research-use-only semaglutide is not a licensed medicine, is not manufactured to…
Follow-up: Reporting a discrepancy without making an allegation Started this topic · Sourcing › Vendor reports · 9 Aug 2024 · 44 likes Reporting a discrepancy without making an allegation Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about…
Oral contraceptives and delayed emptying: what the data shows Replied, post #2 · Practice › Interactions · 4 Jul 2024 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Oral medications with a narrow therapeutic index are the ones where that matters…